Pamrevulab. We will never know if he was a super responder to the drug - but he started his first treatment in May of 2022 and the trial ended in August. Most people do not go 27 months on Gemcitabine and Abraxane alone with stage 4 metastasis. We do think the addition of the trial drug made a difference for him.
His tumor shrunk by half and stayed there and his 19-9 was normal until this past June- creeping up very slowly now.